Target intelligence / Profile preview

12-oxophytodienoate reductase 3 (OPR3) (OPR3)

Target
OPR3
Molecular classification
Enzyme, Oxidoreductase, Old Yellow Enzyme (OYE) family, Flavoprotein
01

Overview

12-oxophytodienoate reductase 3 (OPR3) is a critical flavoprotein enzyme in the jasmonic acid (JA) biosynthetic pathway, primarily characterized in plants such as Arabidopsis thaliana and Solanum lycopersicum [1, 2]. It belongs to the Old Yellow Enzyme (OYE) family and specifically catalyzes the reduction of (9S,13S)-12-oxophytodienoic acid (OPDA) into OPC-8:0, which is subsequently converted to JA via beta-oxidation [3]. Jasmonic acid is a key signaling molecule that regulates various physiological processes, including root growth, fruit ripening, and responses to environmental stresses like wounding and herbivory [4]. While OPR3 is not a target for human therapeutics, its human functional homolog, Prostaglandin reductase 1 (PTGR1), plays a role in the metabolism of eicosanoids and is investigated in cancer and inflammation [5]. In agricultural biotechnology, OPR3 is a target for genetic engineering to improve crop resilience and understand plant-pathogen interactions [6].

Other names
12-oxophytodienoic acid reductase 3OPR312-oxophytodienoate reductaseOPDA reductase 3
02

Mechanism of action

Catalyzes the NADPH-dependent reduction of the C10-C11 double bond in the cyclopentenone ring of (9S,13S)-12-oxophytodienoic acid (OPDA) to form 3-oxo-2-(2'-pentenyl)-cyclopentane-1-octanoic acid (OPC-8:0), a precursor to jasmonic acid.

03

Biological functions

Jasmonic acid biosynthesisLipid metabolismResponse to woundingPlant defense signalingPollen developmentAbiotic stress response
04

Disease associations

Plant pathogen susceptibilityMale sterility (plant)
05

Safety considerations

Essential for plant reproductive fertilityCritical for defense against necrotrophic pathogens and herbivory
06

Biomarkers

Jasmonic acid (JA) levels12-oxophytodienoic acid (OPDA) levelsOPR3 mRNA expression

Beyond the preview

Go deeper on 12-oxophytodienoate reductase 3 (OPR3) (OPR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 12-oxophytodienoate reductase 3 (OPR3) (OPR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call